P-586 Phase II study of docetaxel and celecoxib as first or second linetherapy in patients with advanced NSCLC
Saved in:
| Title: | P-586 Phase II study of docetaxel and celecoxib as first or second linetherapy in patients with advanced NSCLC |
|---|---|
| Authors: | Underhill, C., Hui, R., Links, M., Hawson, G., Chern, B., Yip, D., Blackwell, T., Crombie, C., Boyer, M. |
| Source: | Lung Cancer (01695002). Jul2005 Supplement 2, Vol. 49, pS272-S272. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01695002 |
|---|---|
| DOI: | 10.1016/s0169-5002(05)81079-7 |
